Caspase activation and apoptosis can be initiated by the introduction of se
rine proteinases into the cytoplasm of a cell. Cytotoxic lymphocytes have e
volved at least one serine proteinase with specific pro-apoptotic activity
(granzyme B), as well as the mechanisms to deliver it into a target cell, a
nd recent evidence suggests that other leucocyte granule proteinases may al
so have the capacity to kill if released into the interior of cells. For ex
ample, the monocyte/granulocyte proteinase cathepsin G can activate caspase
s in vitro, and will induce apoptosis if its entry into cells is mediated b
y a bacterial pore-forming protein. The potent pro-apoptotic activity of gr
anzyme B and cathepsin G suggests that cells producing these (or other) pro
teinases would be at risk from self-induced death if the systems involved i
n packaging, degranulation or targeting fail and allow proteinases to enter
the host cell cytoplasm. The purpose of the present review is to describe
recent work on a group of intracellular serine proteinase inhibitors (serpi
ns) which may function in leucocytes to prevent autolysis induced by the gr
anule serine proteinases.